Ajanta Pharma USA Inc recalls

4 recalls.

• Ranolazine Extended-Release Tablets recall (Ajanta Pharma USA Inc)
  DrugClass IIReported October 7, 2026 · Failed Dissolution Specifications: below specification
• Fluphenazine Hydrochloride Tablets recall (Ajanta Pharma USA Inc)
  DrugClass IIIReported September 16, 2026 · Failed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability. Result...
• Fenofibrate Capsules recall (Ajanta Pharma USA Inc)
  DrugClass IIReported July 1, 2026 · CGMP Deviations
• Aripiprazole Tablets USP recall (Ajanta Pharma USA Inc)
  DrugClass IIReported June 24, 2026 · Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.